ArticlePDF Available

Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation

Authors:

Abstract and Figures

To evaluate the influence of end-stage liver disease and orthotopic liver transplantation in the pituitary function and hormone metabolism before and after liver transplantation. In a prospective study, serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and prolactin (PRL) of 30 male patients with cirrhosis were determined two to four hours before and six months after liver transplantation. The results were compared according to the Model for End-stage Liver Disease (MELD). male patients with liver cirrhosis have hypogonadism. FSH was normal, but inappropriately low due to androgen failure; E2 and PRL, on their turn, were high. After liver transplantation, FSH and LH levels increased (p < 0.05), whereas E2 and PRL normalized (p < 0.05). The MELD score did not influence changes in FSH, PRL and LH, however, the more severe the cirrhosis was, the more significant was the normalization of E2 (p = 0.01). Patients with cirrhosis and male hypogonadism have inappropriately normal levels of FSH and LH, associated with an increase in E2 and LRP. After liver transplantation, FSH and LH increased, while E2 and PRL returned to normal. Changes in E2 levels were most pronounced in patients with MELD > 18. The severity of cirrhosis had no influence on FSH, PRL and LH.
Content may be subject to copyright.
ZachariasZacharias
ZachariasZacharias
Zacharias
Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation
421
Rev. Col. Bras. Cir. 2014; 41(6): 421-425
Original ArticleOriginal Article
Original ArticleOriginal Article
Original Article
Hypothalamic-pituitary-gonadal function in men with liverHypothalamic-pituitary-gonadal function in men with liver
Hypothalamic-pituitary-gonadal function in men with liverHypothalamic-pituitary-gonadal function in men with liver
Hypothalamic-pituitary-gonadal function in men with liver
cirrhosis before and after liver transplantationcirrhosis before and after liver transplantation
cirrhosis before and after liver transplantationcirrhosis before and after liver transplantation
cirrhosis before and after liver transplantation
Função do eixo hipotálamo-hipófise-gonadal em homens cirróticos antes e apósFunção do eixo hipotálamo-hipófise-gonadal em homens cirróticos antes e após
Função do eixo hipotálamo-hipófise-gonadal em homens cirróticos antes e apósFunção do eixo hipotálamo-hipófise-gonadal em homens cirróticos antes e após
Função do eixo hipotálamo-hipófise-gonadal em homens cirróticos antes e após
o transplante hepáticoo transplante hepático
o transplante hepáticoo transplante hepático
o transplante hepático
BRUNO T. ZACHARIAS1; JULIO C. U. COELHO,TCBC-PR2; MÔNICA B. PAROLIN3; JORGE E. F. MATIAS,ACBC-PR1;
ALEXANDRE C. T. DE FREITAS,TCBC-PR1; JOSÉ LUIZ DE GODOY3
ABSTRACTABSTRACT
ABSTRACTABSTRACT
ABSTRACT
Objective:Objective:
Objective:Objective:
Objective: To evaluate the influence of end-stage liver disease and orthotopic liver transplantation in the pituitary function and
hormone metabolism before and after liver transplantation. Methods:Methods:
Methods:Methods:
Methods: In a prospective study, serum levels of follicle stimulating
hormone (FSH), luteinizing hormone (LH), estradiol (E2) and prolactin (PRL) of 30 male patients with cirrhosis were determined two
to four hours before and six months after liver transplantation. The results were compared according to the Model for End-stage
Liver Disease (MELD). ResultsResults
ResultsResults
Results: male patients with liver cirrhosis have hypogonadism. FSH was normal, but inappropriately low due
to androgen failure; E2 and PRL, on their turn, were high. After liver transplantation, FSH and LH levels increased (p < 0.05), whereas
E2 and PRL normalized (p < 0.05). The MELD score did not influence changes in FSH, PRL and LH, however, the more severe the
cirrhosis was, the more significant was the normalization of E2 (p = 0.01). ConclusionConclusion
ConclusionConclusion
Conclusion: Patients with cirrhosis and male hypogonadism
have inappropriately normal levels of FSH and LH, associated with an increase in E2 and LRP. After liver transplantation, FSH and LH
increased, while E2 and PRL returned to normal. Changes in E2 levels were most pronounced in patients with MELD > 18. The
severity of cirrhosis had no influence on FSH, PRL and LH.
Key wordsKey words
Key wordsKey words
Key words: Liver Transplantation, Liver Cirrhosis, Pituitary Gland, Hypogonadism.
1. Department of Surgery of the Digestive System, Clinics Hospital, Federal University of Paraná, Curitiba, Paraná – PR, Brazil; 2. Service of
Surgery of the Digestive System and Liver Transplantation, Federal University of Paraná; 3. Liver Transplantation Service, Federal University of
Paraná.
INTRODUCTIONINTRODUCTION
INTRODUCTIONINTRODUCTION
INTRODUCTION
Patients with end-stage liver disease have several
endocrine dysfunctions, which include alterations in the
functioning of the hypothalamic-pituitary-gonadal axis and
the serum levels of sex hormones 1-4. Testicular atrophy,
decrease in libido, impotence, oligospermia, infertility,
loss of body hair, reduction of prostate size,
gynecomastia, vascular spiders, gynecoid distribution of
fat and palm erythema are often found in cirrhotic men
5-10. These findings are more pronounced in patients with
alcoholic cirrhosis due to the direct harmful effect of
ethanol to the testicles. The pathophysiology of
hypogonadism in patients with advanced liver disease is
complex and controversial.
Few studies have evaluated the dysfunction of
the hypothalamic-pituitary-gonadal axis in men with cirrhosis
before and after orthotopic liver transplantation (OLT). The
correlation between changes in serum levels of sex
hormones and the MELD score (Model for End-stage Liver
Disease) has not yet been studied.
The aim of this study was to evaluate the
influence of terminal liver disease and OLT in the pituitary
function and hormone metabolism by measurement of
serum levels of follicle stimulating hormone (FSH), luteinizing
hormone (LH), estradiol (E2) and prolactin (PRL) before and
after liver transplantation.
METHODSMETHODS
METHODSMETHODS
METHODS
Between August 2008 and April 2011, 93 liver
transplants were performed at the Clinics Hospital of the
Federal University of Paraná. The study included all male
patients who did not present any of the following exclusion
criteria: patients submitted to living-donor transplantation,
re-transplantation, multivisceral transplantation, domino
transplant and split liver transplant. Five patients who died
were also excluded. In total, 30 men were selected and
prospectively followed.
We used the Child-Pugh and MELD scores to
determine the severity of liver disease. Among those
DOI: 10.1590/0100-69912014006007
422
Rev. Col. Bras. Cir. 2014; 41(6): 421-425
ZachariasZacharias
ZachariasZacharias
Zacharias
Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation
included in the study, three patients (12%) were Child-
Pugh class A, 6 (24%) class B, and 16 (64%) class C. The
MELD ranged from 10 to 30 points, averaging 17.7 + 4.2
(95% CI 16.1-19.2). We did not consider the additional
scores for cirrhotic patients with associated hepatocellular
carcinoma. To evaluate the relationship between the
severity of liver disease and the variation in the levels of
sex hormones, we divided the study subjects into two groups,
based on MELD classification, 17 patients with MELD <18,
and 13 with MELD e” 18.
The mean age was 51.4 ± 7.6 years. The main
causes of cirrhosis were infection with hepatitis C and alcohol
abuse (Table 1). All patients with alcoholic cirrhosis were
abstinent for more than six months prior to OLT.
After liver transplantation, all patients underwent
the same standard protocol of immunosuppressive therapy,
consisting of cyclosporine or tacrolimus, mycophenolate
mofetil and corticoids.
We collected peripheral blood samples two to
four hours before induction of anesthesia and six months
after liver transplantation, with determination of levels of
FSH, LH, E2 and PRL through commercial immunoassay
kits. We also measured total bilirubin, prothrombin and
creatinine by routine biochemical tests for determining the
MELD score on the day of transplantation.
The study protocol was in accordance with
guidelines of the Helsinki Declaration of 1975, and was
approved by the Ethics Committee of the Clinics Hospital
of the Federal University of Paraná, Brazil (CAAE:
0159.0.208.000-08, CEP Registration: 1712.129 / 2008- 07).
All patients signed an informed consent form to participate
in the study.
Statistical AnalysisStatistical Analysis
Statistical AnalysisStatistical Analysis
Statistical Analysis
The measures of central tendency and dispersion
are expressed as means and standard deviation (mean ±
SD) for symmetrically distributed, continuous variables, and
as median, minimum and maximum values for the ones
with asymmetric distribution.
The estimated difference of continuous variables
with normal distribution were analyzed by parametric tests,
Student’s t test for dependent samples, and ANOVA for
repeated measures, while for asymmetric distribution
variables we employed the non-parametric Wilcoxon and
Friedman ANOVA tests. We applied the McNemar test in
the study of the behavior of biochemical and hormonal
variables according to the reference values, evaluating the
categories’ variations: normal, below and above the
reference value, before and after liver transplantation. The
results were considered statistically significant when p d”
0.05.
RESULTSRESULTS
RESULTSRESULTS
RESULTS
The FSH and LH levels were within normal limits
and increased, respectively, from 8.1 mIU/ml to 13.4 mIU/
ml (p = 0.002) and from 4.6 mIU/mL to 9.9 mIU/ml (p
<0.001) after OLT. Estradiol was initially high, and returned
to normal after liver transplantation (p = 0.001). Prolactin
levels were also elevated preoperatively. After OLT its levels
decreased to normal (p <0.001) (Table 2).
The multivariate analysis based on generalized
linear models showed no influence of age on the date of
transplantation or the etiology of cirrhosis in the hormonal
changes observed.
In both MELD groups we observed a rise
in serum FSH values before and after OLT (p = 0.004), but
without significant difference (p = 0.89) (Figure 1). There
Table 2 Table 2
Table 2 Table 2
Table 2 -Serum levels of FSH, LH, PRL and EE.
HormoneHormone
HormoneHormone
Hormone ReferenceReference
ReferenceReference
Reference Pre-OLTPre-OLT
Pre-OLTPre-OLT
Pre-OLT Post-OLTPost-OLT
Post-OLTPost-OLT
Post-OLT pp
pp
p
FSH 1.5 – 12.4 mUI/mL 8.1 (0.7 – 73.0) 13.4 (2.2 – 92.5) 0.002
HL 1.7 – 8.6 mUI/mL 4.6 (1.3 – 34.0) 9.9 (2.9 – 82.2) < 0.001
E2 < 43 pg/mL 54.7 (26.0 – 466.0) 33.5 (15.5 – 314.0) 0.001
PRL 2.0 – 15.2 ng/mL 16.5 (4.8 – 68.1) 8.4 (3.2 – 29.0) < 0.001
OLT = Orthotopic Liver Transplantation; FSH = Follicle Stimulating Hormone; HL = Luteinizing Hormone; E2 = Estradiol; PRL = Prolactin.
Table 1 Table 1
Table 1 Table 1
Table 1 -Clinical and Demographic Characteristics of
patients.
FeaturesFeatures
FeaturesFeatures
Features PatientsPatients
PatientsPatients
Patients
Number 30
Age (in years)
Mean ± Sd 51.4 ± 7.6
Variation 25 – 64
IC 95% 48.6 – 54.3
Gender (male/female) 30/0
Etiology of cirrhosis N(%)
HCV infection 10 (33.33)
Alcohol abuse 8(26.67)
NASH 3(10.0)
HBV infection 2(6.67)
Hemochromatosis 2(6.67)
Other 5(16.67)
Associated Hepatocarcinoma 4(13.33)
CI = confidence interval; SD = standard deviation; HCV = hepatitis C
virus; HBV = hepatitis B virus; NASH =
Nonalcoholic Steatohepatitis
.
ZachariasZacharias
ZachariasZacharias
Zacharias
Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation
423
Rev. Col. Bras. Cir. 2014; 41(6): 421-425
was an increase in HL in the MELD group < 18 (p = 0.01),
while there was no change in the MELD group e” 18 (p =
0.26). Nor was there a significant difference between groups
(p = 0.89) (Figure 2). There was a drop in estradiol values
after OLT both in the group with MELD <18 (p = 0.05) and
in the one with MELD e” 18 (p = 0.005), being more
pronounced in the group with Meld e” 18 (p = 0.006) (Fi-
gure 3). There was a reduction in serum prolactin levels in
the MELD group <18 (p = 0.03) and MELD e” 18 (p =
0.005), with no statistically significant difference (p = 0.07)
(Figure 4).
DISCUSSIONDISCUSSION
DISCUSSIONDISCUSSION
DISCUSSION
Male patients with cirrhosis have a number of
changes in the regulation of their sex hormones, resulting
in hypogonadism and feminization. End-stage liver disease
causes dysfunction in the hypothalamic-pituitary-gonadal
axis and hormonal peripheral metabolism 1,2,11,12, resulting
in a significant deterioration in quality of life 3-10.
Our prospective study showed that cirrhotic men
have significant alterations in the pituitary regulatory
functions, and that these disorders are completely reversed
after liver transplantation.
The FSH and HL were at levels within their
reference values, and increased after OLT 13. These data
confirm the results of previous studies. However, it is
important to note that serum levels of these hormones were
inappropriately low, given the androgen failure evidenced
in these patients 7,14,15. In fact, one would expect them to
suffer a compensatory increase due to low serum
testosterone levels. Our results showed that six months after
transplantation the values of FSH and HL showed a
Figure 4 -Figure 4 -
Figure 4 -Figure 4 -
Figure 4 - Liver Transplantation Orthotopic (OLT); prolactin (PRL).
Reduction in levels of PRL in the MELD groups <18 (p
= 0.03) and e” 18 (p = 0.005), with no difference
between them (p = 0.07).
Figure 3 Figure 3
Figure 3 Figure 3
Figure 3 -Orthotopic Liver Transplantation (OLT); estradiol (E2).
Reduction in E2 levels in groups MELD <18 (p = 0.05)
and MELD score e” 18 (p = 0.005), more pronounced
in the MELD group e” 18 (p = 0.01).
Figure 2 -Figure 2 -
Figure 2 -Figure 2 -
Figure 2 - Orthotopic liver transplantation (OLT); luteinizing
hormone (LH). Increases in serum LH levels in the MELD
group <18 (p = 0.01), not observed in the MELD group
e” 18 (p = 0.26), with no difference between them (p
= 0.89).
Figure 1 -Figure 1 -
Figure 1 -Figure 1 -
Figure 1 - Orthotopic liver transplantation (OLT); follicle
stimulating hormone (FSH). Increased serum FSH levels
in both groups MELD <18 and MELD e” 18 (p = 0.04),
with no difference between them (p = 0.89).
Before OLT6 months after OLTBefore OLT6 months after OLT
Before OLT6 months after OLT
Before OLT6 months after OLT
424
Rev. Col. Bras. Cir. 2014; 41(6): 421-425
ZachariasZacharias
ZachariasZacharias
Zacharias
Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation
significant increase, suggesting that the liver disease had a
direct influence on this abnormality, which is consistent with
the available literature on the subject 3,12,13 16.
The exact cause of this central dysfunction has
not been clearly elucidated. It is speculated that liver cirrhosis
alone can cause a malfunction of the hypothalamic-
pituitary-gonadal axis1,3,10. Furthermore, high circulating
levels of estradiol and prolactin also contribute to
hypogonadism2,3, either by regulatory suppression or by
direct inhibition of the testicular function10. The results also
showed that both the PRL and E2 were at levels above
normal in patients with end-stage liver disease, with
normalization after OLT, in line with previous studies 1,17,18.
The increase in serum levels of E2 is primarily due to
increased peripheral conversion of androgens into estrogens
and reduction in liver clearing function 5,7. Portal hypertension
can lead to a diversion of blood flow from the liver to
peripheral tissues, resulting in a further increase in the
conversion of steroids into estrogens8. Although some studies
2,19,20 have established a correlation between increased PRL
in cirrhosis and hyperestrogenemia, the mechanism that
leads to hyperprolactinemia is not yet clear.
Another important finding of our study is the
correction between these hormonal changes and the MELD
score at the time of transplantation. It was found that the
severity of liver disease has no influence on changes in
FSH, LH and PRL (p = 0.89, p = 0.89 and p = 0.07,
respectively) after OLT. This may be due to the limited
number of patients included in this analysis.
However, E2 values decreased after liver
transplantation in direct proportion with the worst liver
function (p = 0.01). Furthermore, the higher the value of
MELD at the time of OLT, the more significant the
normalization of estradiol (p = 0.006).
Finally, after the evaluation of the impact of liver
transplantation in the hypothalamic-pituitary-gonadal
dysfunction in male cirrhotic patients, we observed that all
hormone levels are normal six months after transplantation.
This conclusion is consistent with the literature 3,7,10,13,16-18.
Seehofer
et al
, after a five-year follow-up of their patients,
found that this improvement is persistent 12.
The present study demonstrated that male
patients with end-stage liver disease have inappropriately
low levels of FSH and LH due to androgenic failure, and
elevated serum E2 and PRL. After liver transplantation, FSH
and LH values increased, while E2 and PRL returned to
normal. Changes in estradiol are more pronounced in
patients with higher MELD (MELD e” 18). Changes of FSH,
PRL and LH did not vary according to the severity of liver
disease.
RESUMORESUMO
RESUMORESUMO
RESUMO
Objetivo: Objetivo:
Objetivo: Objetivo:
Objetivo: avaliar a influência da doença hepática terminal e do transplante hepático ortotópico na função hipofisária e no
metabolismo hormonal através da aferição dos níveis séricos dos hormônios folículo estimulante (FSH), hormônio luteinizante (HL),
estradiol (E2) e prolactina (PRL) antes e após o transplante hepático. Métodos: Métodos:
Métodos: Métodos:
Métodos: em um estudo prospectivo, níveis séricos dos
hormônios folículo estimulante (FSH), hormônio luteinizante (HL), estradiol (E2) e prolactina (PRL) de 30 paciente masculinos com
cirrose foram determinados duas a quatro horas antes e seis meses após o transplante hepático. Os resultados foram comparados
de acordo com o
Model for End-stage Liver Disease
(MELD). Resultados: pResultados: p
Resultados: pResultados: p
Resultados: pacientes masculinos com cirrose hepática apresentam
hipogonadismo. O FSH encontravam-se normais, porém inapropriadamente baixos devido à falência androgênica; já o E2 e o PRL
estavam elevados. Após o transplante hepático, os níveis de FHS e HL aumentaram (p < 0,05), enquanto o E2 e o PRL normalizaram
(p < 0,05). O MELD não influenciou as alterações no FSH, HL ou PRL, todavia, quanto mais grave a cirrose, mais significante foi a
normalização do E2 (p=0,01). Conclusão: Conclusão:
Conclusão: Conclusão:
Conclusão: pacientes masculinos com cirrose e hipogonadismo apresentam níveis inapropriadamente
normais de FSH e HL, associados com elevação do E2 e PRL. Após o transplante hepático, FSH e HL aumentaram, enquanto E2 e PRL
retornaram aos valores normais. As alterações nos níveis de E2 foram mais pronunciadas em pacientes com MELD > 18. A gravidade
da cirrose não teve influência no FSH, HL e PRL.
DescritoresDescritores
DescritoresDescritores
Descritores: Transplante de Fígado, Cirrose Hepática, Hipófise, Hipogonadismo.
REFERENCESREFERENCES
REFERENCESREFERENCES
REFERENCES
1. Zietza B, Locka G, Placha B, Drobnikb W, Grossmanna J,
Scholmericha J, Strauba R. Dysfunction of the hypothalamic-
pituitary-glandular axes and relation to Child–Pugh classification
in male patients with alcoholic and virus-related cirrhosis. Eur J
Gastroenterol Hepatol 2003; 15: 495-501.
2. Gonzales PH, Rhoden CR, Luz C, Correa G, Marbosa-Coutinho
LM, Oliveira MC. Male gonadal function, prolactin secretion and
lactotroph population in an experimental model of cirrhosis. Braz
J Med Biol Res 2007; 40: 1383-8.
3. Heneghan M, Selzner M, Yoshida E, Mullhaupt B. Pregnancy and
sexual function in liver transplantation. J Hepatol 2008; 49: 507–19.
4. Sorrell J, Brown J. Sexual Functioning in Patients With End-Stage
Liver Disease Before and After Transplantation. Liver Transpl 2006;1
2: 1473-7.
5. Southren L, Gordon G, Olivo J, Rafii F, Rosenthal W. Androgen
Metabolism in Cirrhosis of the Liver. Metabolism 1973; 22: 695-702.
6. Guichelaar M, Malinchoc M, Sibonga J, Clarke B, Hay J.
Immunosuppressive and Postoperative Effects of Orthotopic Liver
Transplantation on Bone Metabolism. Liver Transpl 2004; 10: 638–
47.
ZachariasZacharias
ZachariasZacharias
Zacharias
Hypothalamic-pituitary-gonadal function in men with liver cirrhosis before and after liver transplantation
425
Rev. Col. Bras. Cir. 2014; 41(6): 421-425
7. Guechot J, Chazouilleres O, Loria A, Hannoun L, Balladur P, Parc R,
Giboudeau J, et al. Effect of liver transplantation on sex-hormone
disorders in male patients with alcohol-induced or post-viral hepatitis
advanced liver disease. J Hepatol 1994; 20: 426-30.
8. Nolte W, Schindler C, Figulla H, Wuttke W, Huefner M, Hartmann
H, Ramadori G. Increase of serum estradiol in cirrhotic men treated
by transjugular intrahepatic portosystemic stent shunt. J Hepatol
2001; 34: 818-24.
9. Burra P, Germani G, Masier A, Martin E, Gambato M, Salonia A,
Bo P, et al. Sexual dysfunction in chronic liver disease: Is liver
transplantation an effective cure? Transplantation 2010; 89: 1425-
9.
10. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic
diseases. Eur J Endocrinol 2005; 152: 501–13.
11. Mowat N, Edwards C, Fisher R, McNeilly A, Green R, Dawson A.
Hypothalamic-pituitary-gonadal function in men with cirrhosis of
the liver. Gut 1976; 17: 345-50.
12. Seehofer D, Steinmueller T, Graef K, Rayes N, Wiegand W, Tullius
S, Settmacher U, et al. Pituitary Function Test and Endocrine
Status in Patient with Cirrhosis of the Liver before and after Hepatic
Transplantation. Ann Transplant 2002; 7: 32–7.
13. Floreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, Fagiuoli
S, et al. Bone Metabolism and Gonad Function in Male Patients
Undergoing Liver Transplantation: A Two-Year Longitudinal Study.
Osteoporos Int 2001; 12: 749–54.
14. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, Pietrzak B, Wielgos
M, Zieniewicz K, Krawczyk M. Menstrual Cycle and Sex Hormone
Profile in Perimenopausal Women After Liver Transplantation.
Transplant Proc 2006; 38: 2909–12.
15. Jabiry-Zienjewicz Z, Kaminski P, Bobrowska K, Pietrzak B, Wielgos
M, Zieniewicz K, Krawczyk M. Menstrual Function in Female Liver
Transplant Recipients of Reproductive Age. Transplant Proc 2009;
41: 1735–9.
16. Guichelaar M, Malinchoc M, Clarke B, Hay J. The Effect of
Hypogonadism Before and After Orthothopic Liver Transplantation
(OLT) on Bone Merabolism. J Hepatol 2003; 38: 60-6.
17. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez
OM, Ordi J, et al. Bone Disease After liver transplantation: A long-
term prospective study of bone mass changes, hormonal status
and sistomorphometric characteristics. Osteoporos Int 2001; 12:
484–92.
18. Aller R, de Luis D, Moreira V, Boixeda D, Moya J, Fernandez-
Rodriguez C, San Román A, et al. The effect of liver transplantation
on circulating levels of estradiol and progesterone in male patients:
parallelism with hepatopulmonary syndrome and systemic
hyperdynamic circulation improvement. J Endocrinol Invest 2001;
24: 503-9.
19. Morgan M, Jakobovits A, Gore, M, Willis M, Sherlock S. Serum
prolactin in liver disease and its relationship to gynaecomastia. Gut
1978; 19: 170-4.
20. Farthing M, Green J, Edwards C, Dawson A. Progesterone,
prolactin, and gynaecomastia in men with liver disease. Gut 1982;
23: 276-9.
Received 16/01/2014
Accepted for publication 20/03/2014
Conflict of interest: none.
Source of funding: none.
Mailing address:Mailing address:
Mailing address:Mailing address:
Mailing address:
Bruno T. Zacharias
E-mail: brunozacharias@hotmail.com
... A possible cause of decreased sexual function in patients suffering from liver disease is an abnormality of the hypothalamic-pituitary-gonadal axis [10,11]. In sexuality and reproduction, Sex enhancers play a crucial role. ...
Article
Full-text available
Objective The purpose of this study was to examine the sex lives of male cirrhotic patients organic factors affect them. Method We did an observational study of 220 cirrhotic men’s satisfaction with their sexual lives. Assessment of sex satisfaction was carried out using the New Sexual Satisfaction Scale. The frequency of intercourse and masturbation was estimated. Then, the levels of albumin, total bilirubin, vitamin D, and sex steroids were examined. Ascites and sarcopenia subgroups of our patients were stratified. Results Along with sex steroids, albumin, total bilirubin, and vitamin D all had an impact on how satisfying sex was (r = 0.22), (r = 0.24), and (r = −0.17) affected sex satisfaction. There were strong positive correlations between vitamin D (r = 0.33), albumin (r = 0.59), and free testosterone, along with a negative correlation between total bilirubin (r = −0.63) and free testosterone. An imbalance in sex steroid levels was observed, leading to decreased frequency of intercourse(p < 0.0001), weakened erections(p < 0.0001), and reduced quality of orgasm (p < 0.0001). Significant new sex behavior changes were found, such as an increase in masturbation. Physical limitations such as ascites and sarcopenia also impacted the decreasing sex life. Conclusion The sex life of cirrhotic men is affected. The decrease in the frequency of intercourse and sexual satisfaction is noticeable in male patients and leads to increased masturbation. Free Testosterone, vitamin D, albumin, and bilirubin play role in their sex life. In addition, ascites and sarcopenia not only affect their sex life but also hamper the quality of their well-being.
... The MELD score was not different between men with and without hypogonadism which was similar to our findings. Another study also showed no association between the MELD score and gonadal hormones (LH, FSH, and prolactin) except estradiol [26]. Another study concluded that FT can be a novel prognostic marker for increased mortality and the need for LT independent of the MELD score [27]. ...
Article
Full-text available
Background and aims: Liver cirrhosis influences gonadal hormone metabolism by multiple mechanisms and causes gonadal dysfunction. This study aimed to study sex hormones in males with cirrhosis and determine their correlation with prognostic scores. Methods: An observational study was conducted between October 2019 and August 2021 in India. Sixty males with liver cirrhosis and 60 healthy age-matched controls were enrolled. Serum-free testosterone (T), estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (Prl) were checked. Child-Turcotte-Pugh (CTP) and model for end-stage liver disease (MELD-Na) scores were calculated. Results: Mean age of patients was 46.9±8.38 years. Forty-three were alcoholics. A total of 29 (48.33%) patients had low levels of free T. Cirrhotic males had lower testosterone and higher estradiol levels and lower T:E2 ratio compared to controls. Levels of luteinizing hormone, follicle-stimulating hormone, and prolactin were comparable. Lower testosterone was significantly associated with advancing age, alcoholism, duration of cirrhosis, loss of libido, and ascites. The higher the CTP scores, the lower the free testosterone levels and the higher the E2 levels. There was no significant association between low free testosterone levels and MELD-Na score. Conclusions: Age, alcohol, duration of disease, and low albumin levels are risk factors for hypogonadism in cirrhosis. There was a significant positive correlation between low free testosterone levels and poor CTP scores.
... patients. The findings of our study were similar to the findings by Balakrishnan and and Rajeev 6 and Zacharias et al. 10 In a study by Hong et al., 11 the most common cause of liver cirrhosis was found to be hepatitis B virus (56%). ...
Article
Full-text available
Background: With the growing incidence of liver cirrhosis among Asians, the use of a biomarker such as prolactin indicates the severity of the disease, its complications, and serves as a tool for the early intervention. Aims and Objectives: The aims of this study were to assess the correlation of serum prolactin level to the Child-Pugh Scoring System in liver cirrhosis patients and to find out its prognostic importance in liver cirrhosis. Materials and Methods: This is a cross-sectional study including 60 patients of liver cirrhosis. Complete history taking, physical examination, and relevant investigations were done. Frequency and percentage were calculated and Chi-square test was applied for significance. Correlation was assessed using Spearman’s correlation coefficient. Results: Mean age was 44±12.8 years. Cirrhosis was alcohol induced in 55%, hepatitis B related in 18.3%, and other causes related in 7.8%. Mean prolactin levels were 18.1±11.3 μg/l. Strong positive correlation was found between prolactin level and bilirubin level (rs=0.372, P=0.003) and prolactin level and prothrombin time (rs=0.490, P=0.003). Statistically significant association was found between Child-Pugh score and prolactin level (x2=12.2, P=0.003). We found no significant association of prolactin level with age, albumin, creatinine, ascites, esophageal varices, etiology of cirrhosis, and hepatic encephalopathy. Conclusion: We observed that there was a strong correlation between Child-Pugh score and serum prolactin level. Although, Child-Pugh scoring system is a predictor of morbidity in liver cirrhosis patients, serum prolactin level can also be used as an indicator for predicting patients at high risk of developing complications and mortality due to liver cirrhosis.
... FSH and LH have also been known to play roles in non-reproductive functions, while increased levels of FSH and LH have been reported to be the biomarkers for testicular damage and some secondary pathological consequences [108,109]. The dysregulation of the HPG axis has been associated with diseases like chronic kidney disease and liver cirrhosis [110][111][112][113]. Also, the incidence of disorders of HPG axis ranging from hypothyroidism to neurodegenerative senescence could be a likely consequence [102,114,115]. ...
Article
Full-text available
Coronavirus disease 2019 (COVID-19), which resulted from the pandemic outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes a massive inflammatory cytokine storm leading to multi-organ damage including that of the brain and testes. While the lungs, heart, and brain are identified as the main targets of SARS-CoV-2-mediated pathogenesis, reports on its testicular infections have been a subject of debate. The brain and testes are physiologically synchronized by the action of gonadotropins and sex steroid hormones. Though the evidence for the presence of the viral particles in the testicular biopsies and semen samples from COVID-19 patients are highly limited, the occurrence of testicular pathology due to abrupt inflammatory responses and hyperthermia has incresingly been evident. The reduced level of testosterone production in COVID-19 is associated with altered secretion of gonadotropins. Moreover, hypothalamic pathology which results from SARS-CoV-2 infection of the brain is also evident in COVID-19 cases. This article revisits and supports the key reports on testicular abnormalities and pathological signatures in the hypothalamus of COVID-19 patients and emphasizes that testicular pathology resulting from inflammation and oxidative stress might lead to infertility in a significant portion of COVID-19 survivors. Further investigations are required to monitor the reproductive health parameters and HPG axis abnormalities related to secondary pathological complications in COVID-19 patients and survivors.
... It is also of paramount importance to determine whether the LT is able to restore the QOL [4,13]. Several studies have evaluated the various aspects of QOL after LT, such as growth and development, return to school and work, sex life and hormonal changes, both in short-term and long-term after the transplant [3,[14][15][16][17][18][19]. These studies have documented a significant QOL improvement, with most patients returning to normal life. ...
Article
Full-text available
Aim: This study goal was to evaluate the long-term quality of life of patients who underwent cadaveric liver transplants (CLT) in two Brazilian hospitals. Methods: Medical records of all patients who underwent CLT and survived over 10 years were revised. The international validated questionnaire Short-Form 36 was employed to assess the quality of life. Patients data were obtained from electronic medical records and study protocols. Results: A total of 342 patients underwent CLT, of which 129 were alive and 93 fully answered the questionnaire and were included in the study. The group consisted of 62 men (66.6%) and 31 women (33.4%), with average age of 40.1±15.9 years. Follow-up time was 16±4.1 years. The most common indication of CLT was hepatic cirrhosis caused by hepatitis C virus, 24.7%. Transplanted patients had lower scores than the general population in mental health [62.9 (95%CI: 60.1-65.7,) vs. 74.5, p < 0.001]. In all other domains, transplanted patients had similar (emotional aspect limitiation, pain, and general health status) or superior (physical aspect limitation, social aspects, functional capacity, and vitality) scores than the general population. Functional capacity score was lower in patients with long-term complications, who were aged more than 50-years, and unemployed. Conclusions: The quality of life in patients with more than 10 years after CLT was similar or superior than the general population, except for the mental health domain.
Article
Full-text available
Background Testosterone is an important anabolic hormone responsible for maintaining body composition and muscle mass and circulates mostly albumin‐bound, or sex hormone binding globulin (SHBG)‐bound or free in the plasma. Of these fractions, the latter is bioactive and exerts the androgenic effects on male population. Liver cirrhosis, the advanced stage of any chronic liver disease characterized by permanent distortions to the hepatic architecture, disrupts the hypothalamic‐pituitary‐gonadal axis, leading to diminished levels of free testosterone and hypogonadism. Methods We retrieved the PubMed database to provide a synopsis of testosterone's physiology and action and summarize the effect of sarcopenia in pre‐cirrhotic and cirrhotic patients. Moreover, we scoped to provide insight into the relationship of testosterone levels with sarcopenia, frailty and survival in cirrhotic and non‐cirrhotic population as well as to discuss the efficacy of exogenous testosterone supplementation on the anthropometric parameters and survival of those patients. Results Low testosterone levels have been associated with sarcopenia, reduced body lean mass, decreased bone mineral density and frailty, thus leading to increased morbidity and mortality especially among cirrhotic patients. Furthermore, exogenous testosterone administration significantly ameliorated body composition on patients with chronic hepatic disease, without significant adverse effects. However, the current literature does not suggest any significant effect on survival of those patients. Moreover, the long‐term safety of testosterone use remains an open question. Conclusion Low serum testosterone is strongly correlated with sarcopenia, frailty, higher rate of hepatic decompensation and mortality. Nonetheless, exogenous supplementation of testosterone did not ameliorate the liver‐related outcomes and complications.
Research Proposal
Full-text available
Apresenta-se nessa proposta de pesquisa elementos para uma nova forma de abordagem para a questão da hiperglicemia infanto-juvenil e suas tendências concretas ou idiopáticas. Foram avaliados um considerável e consistente volume de artigos especializados em endocrinologia, neurologia, neuro-endocrinologia, esporte de alta performance, psiquiatria, e outros temas afins. Após esta revisão, demonstra-se que para se compreender, de fato, as disfunções na glicemia humana (hiperglicemia e hipoglicemia) é preciso internalizar e abandonar a visão cartesiana da medicina entendendo que esse assunto, extremamente complexo na sua dinâmica, altamente não linear, com sistemas de feedback (com alterações dinâmicas reversíveis tipo histereses – o caminho de ida não é igual ao caminha de volta), auto-organizações, acoplamentos, e outros efeitos psíquicos, químicos, físicos, físicos-químicos, bioquímicos, e biofísicos, afins. E tudo isso acoplado ao fato de vivermos em um mundo onde o estresse da vida e o estresse no corpo causado por agentes externos como poluição e campos eletromagnéticos (EMF) oriundos dos celulares, wifi, antenas, rede elétrica, e outros equipamentos geradores de ondas eletromagnéticas que induzem efeitos no corpo humano desconhecidos ou muito mal estudados e compreendidos. Para entender a dinâmica glicêmica humana de forma profunda e correta é compulsório se considerar, pelo menos, nas suas complexidades os aspectos bioquímicos (hormônios e suas cinéticas), biofísicos afins, endocrinológicos afins, neurológicos afins, neuro endocrinologia afins, psíquicos afins, e acoplamentos com o mundo exterior via a cognição e sentidos. Resumindo, para se aprofundar no estudo das anomalias da glicemia humana para fins de diagnóstico preciso, é fundamental compreender-se profundamente o que se segue, onde se apresenta os tópicos relevantes acima mais explicitamente e se busca uma consiliência de interpretação e ação.
Article
Background & Aims Cirrhosis disrupts the hypothalamic‐pituitary‐gonadal axis causing low testosterone. Testosterone deficiency is associated with sarcopenia and osteopenia, leading to a state of frailty and worse clinical outcomes, morbidity, and mortality. We aimed to conduct a systematic review on the relationship between serum testosterone and laboratory, anthropometric, and clinical outcomes in observational and interventional studies in cirrhosis. Methods PubMed and EMBASE were searched from inception through August 27, 2020, and reviewed independently by two investigators; a third reviewer solved disagreement. A qualitative summary of relevant findings was done. Methodological quality was assessed using the Newcastle Ottawa Scale for non‐interventional studies and the Cochrane Risk of Bias for interventional studies. Results Out of 3,569 articles, 15 met inclusion criteria with 6 observational studies of 1,267 patients and 9 interventional studies of 580 patients. In observational studies, low serum testosterone level was associated with sarcopenia, shorter median time to hepatic decompensation, transplant requirement, higher model for end‐stage liver disease (MELD) scores, and death in cirrhotic patients. 9 interventional studies (361 treated with testosterone vs 219 placebo, 1‐36 months) showed that testosterone supplementation improved serum testosterone, appendicular mass, and bone mineral density. However, no trial reported improvement in liver‐related scores, complications, readmission rates, or death. Conclusions Low serum testosterone is associated with increased morbidity and mortality in cirrhosis patients. Testosterone supplementation improved intermediate endpoints, but there was no conclusive data on clinical outcomes. Testosterone supplementation may be a promising strategy to improve frailty and decrease significant clinical complications in cirrhosis.
Article
Blood tests to assess the endocrine system are commonly performed in patients admitted to hospital. This may be because an endocrinopathy is thought to be aetiological in the presenting disease or suspected as an incidental occurrence by the clinician. Many patients, in addition to the pathology leading to admission, frequently have one or more comorbidities, a change in nutritional status and polypharmacy. Added to this, presentation with acute illness is a major life stress. All of these are likely to impact on one or more endocrine axes, although often only transiently. Endocrine evaluation in the vast majority of cases can be safely deferred to the outpatient setting. This article considers the most common endocrine anomalies discovered in hospital, the confounders, and provides guidance on how to investigate these further.
Chapter
Environmental and hereditary factors contribute to increased risk of developing endometrial cancer. An understanding of risk factors can guide screening modalities in premenopausal and postmenopausal women. Attention is drawn to certain anatomic abnormalities that prevent vaginal bleeding—the most common symptom related to cancer. Diagnostic tests that are available to pursue various aspects of the diagnosis in a sequential fashion are described, the most important of which is the endometrial biopsy. Recommendations for screening and diagnosis in the asymptomatic as well as the symptomatic patients are summarized. Surgical staging represents the final event in the diagnostic workup. Instances when such staging can be modified to deal with various comorbidities are delineated.
Article
Full-text available
In this the 11th Forum, we have reviewed many of the issues pertaining to sexuality and sexual function in the liver transplant recipient. It is disappointing that despite forty years of OLT, only a relatively small literature exists in relation to many of these topics, particularly the area of sexual health. As hepatologists and transplant physicians, much is made of graft and patient survival and indeed it is correct to do so. However, it is clear that our patients wish to, and do form and maintain normal healthy sexual relationships. Yet, this area of transplantation has been largely neglected not just in OLT, but also across other organs. Indeed, despite the many successful pregnancies that do occur in our transplant recipients, the management of such patients has been derived from largely self-reported patient series, and the criticism of all such series is that there exists a reporting bias of predominantly successful outcomes. That said, the multi-disciplinary transplant team should not fear addressing issues of sexuality and sexual health, but rather encourage it. Indeed, all concerned, both patients and healthcare providers alike may be pleasantly surprised by the responses and the interest in the topic!
Article
Full-text available
Hypothalamic-pituitary-gonadal function was studied in 37 cirrhotic males, 25 of whom were alcoholic. Irrespective of aetiology, cirrhotic patients had significantly reduced free testosterone concentrations. Despite low free testosterone concentrations and reduced or absent spermatogenesis, basal levels of luteinizing hormone (LH) and follicle stimulating hormone (FSH) were normal in nearly all patients, suggesting impaired function of the hypothalamic-pituitary-gonadal axis. In 14 cirrhotic men, seven of whom had gynaecomastia, the ability of the pituitary to secrete LH and FSH in response to exogenous gonadotrophin releasing-hormone (LH/FSH-RH) was asssessed. A normal LH response to LH/FSH-RH was obtained in patients without gynaecomastia. An exaggerated LH response was found in four of seven with gynaecomastia, suggesting Leydig cell failure. The Leydig cell response to exogenous gonadotrophin in eight consecutive cirrhotic patients was probably abnormal but difficult to interpret as all but one were within conventionally accepted limits of normality. The patients without gynaecomastia gave a normal or minimally exaggerated FSH response to LH/FSH-RH. Six of seven with gynaecomastia gave a markedly exaggerated response suggesting failure of spermatogenesis, and all tested were either azoospermic of oligospermic. The single patient with a normal FSH response had a normal sperm count. The pituitary cells can therefore respond to LH/RSH-RH and the Leydig cells of the testes show some response to exogenous gonadotrophin. Similar abnormalities in hypothalamic-pituitary-gonadal function have recently been described in patients with normal liver function on chronic oestrogen therapy.
Article
Full-text available
Plasma progesterone was raised in 36 of 50 (72%) men with liver disease compared with 20 healthy male control subjects. Plasma progesterone was significantly higher in men with non-alcoholic cirrhosis with gynaecomastia than those without, but no similar relationship was found in men with alcoholic fatty change and alcoholic cirrhosis. Hyperprolactinaemia was found in 14% of men with liver disease but levels were unrelated to the presence of gynaecomastia. Increased circulating levels of progesterone and prolactin alone do not explain the development of gynaecomastia in patients with liver disease, but progesterone may be an additional factor acting in association with the known disturbances of other sex steroids.
Article
The goal of liver transplantation is not only to ensure patient long-term survival but also to offer the opportunity to achieve psychologic and physical integrity. Quality of life after liver transplantation may be affected by unsatisfactory sexual function. Before liver transplantation, sexual dysfunction and sex hormone disturbances are reported in men and women mainly due to abnormality of physiology of the hypothalamic-pituitary-gonadal axis and, in some cases, origin of liver disease. Successful liver transplantation should theoretically restore hormonal balance and improve sexual function both in men and women, thus improving the reproductive performance. However, after transplantation, up to 25% of patients report persistent sexual dysfunction, and approximately one third of patients describe the appearance of de novo sexual dysfunction. Despite the described high prevalence of this condition, epidemiologic data are relatively scant. Further studies on pathophysiology and risk factors in the field of sexual function after liver transplantation along with new strategies to support and inform patients on the waiting list and after surgery are needed.
Article
End-stage liver failure is associated with severe abnormalities in menstrual and reproductive function. These abnormalities may be reversed by successful orthotopic liver transplantation (OLT). The aim of the study was to investigate menstrual patterns and sex hormone profiles among female liver transplant recipients of reproductive age. The study group consisted of 24 women of reproductive age with end-stage liver failure who underwent successful OLT. Menstrual patterns and sex hormone profiles were analyzed before as well as 3 and 12 months after OLT. Twenty-seven healthy women of reproductive age served as controls. Biochemical parameters of liver function were assessed before and after OLT. Amenorrhea was the most commonly observed abnormality of menstrual cycle in women with end-stage liver failure (71% of patients). The recurrence of regular menstrual cycles was observed in 35% of patients 3 months after OLT. The percentage increased to 70% at 1 year after grafting and was clearly associated with stabilization of liver function. Similar levels of follicle stimulation hormone (FSH), luteinizing hormone (LH), prolactine (PRL), and testosterone (T) as well as lower levels of estradiol (E(2)), dehydroepiandrostendione sulphate (DHEA-S), and progesterone, (P) were observed in patients with liver failure compared with healthy women. We observed normalization of E(2) and DHEA-S levels after OLT. Amenorrhea, the most common menstrual disturbance in women with end-stage liver failure, may be reversed by OLT. One year after OLT menstrual bleedings were noted in 74% of patients of reproductive age. The recurrence of reproductive function indicated the need for effective and safe family planning methods in that group of patients.
Article
Serum immunoreactive prolactin was measured in 150 patients with liver disease of varying aetiology and severity and in 45 control subjects. The upper limit of the reference range for serum prolactin was 331 mU/l. Eighteen patients with liver disease (12%) had unexplained hyperprolactinaemia. No relationship existed between the prolactin value and the sex of the patient, the aetiology of the liver disease, the severity of the liver disease, or the presence of gynaecomastia. The cause of the hyperprolactinaemia in patients with liver disease and its clinical implications need further investigation.
Article
Androgen metabolism was studied in male patients with cirrhosis of the liver. The plasma level, metabolic clearance, and production rates of testosterone were decreased while the conversion ratio and rate transport constant of testosterone to androstenedione was increased. Administration of testosterone produced a marked increase in the metabolic clearance rate of testosterone indicating that parenchymal hepatic dysfunction per se was not the cause for the reduced clearance rate. Moreover, the patients were found to have normal testicular reserve for the biosynthesis of testosterone as indicated by an almost fourfold increase in the plasma concentration of testosterone following the administration of human chorionic gonadotropin. These data demonstrate that the reduced production rate of testosterone in male cirrhotics is not due primarily to testicular disease but possibly reflects hypothalamic-pituitary suppression secondary to increased circulating estrogens. The increase in the rate of conversion of testosterone to androstenedione, found in the present study, is consistent with this hypothesis. The present investigation thus provides quantitative data on the hypogonadal state in cirrhosis and suggests possible mechanisms for the alteration in androgen metabolism.
Article
The effects of liver transplantation on the pituitary-gonadal axis and sex-hormone metabolism were evaluated by studying hormonal status (androgens, oestrogens, and gonadotropins) and sex-hormone-binding globulin levels in men with advanced liver disease of both alcoholic and viral origins. Comparison of the results prior to and 6 months after liver transplantation showed that successful liver transplantation in men induced significant differences in sex-hormone levels and in pituitary-gonadal function in both alcoholic and post-hepatitis patients. Plasma testosterone and dihydrotestosterone levels increased, oestrogen (oestrone and oestradiol) and androstenedione levels fell while gonadotropin (FSH and LH) levels increased. There was also a fall in plasma prolactin levels. Sex-hormone binding globulin plasma levels were elevated prior to transplantation and decreased thereafter. These data show that male patients with advanced liver disease have biological hypogonadism and feminization, irrespective of the aetiology, and that these abnormalities rapidly improve after successful liver transplantation. Therefore in men with advanced liver disease the biochemical signs of sex hormone disturbance are reversible and may be largely related to the liver disease.
Article
After liver transplantation there is a high incidence of fractures, with important rates of bone loss during the first months. However, the long-term evolution of bone mass and metabolism parameters have been scarcely studied. In order to determine the incidence and risk factors involved in the development of skeletal fractures and to analyze the long-term evolution of bone mass, bone turnover and hormonal status after liver transplantation, a 3-year prospective study was performed in 45 patients following liver transplantation. Serum osteocalcin, parathyroid hormone (PTH), 25-hydroxyvitamin D (25-OH D) and testosterone levels (men), and bone mass at the lumbar spine and femur were measured before and sequentially at different time points during 3 years. Spinal X-rays were obtained during the first year. Histomorphometric analysis of bone biopsies obtained in 24 patients within the first 12 hours after surgery and 6 months after transplantation was performed. Fifteen patients (33%) developed fractures after liver transplantation, and pre-transplant risk factors for fractures were age and low bone mass (odd's ratio for osteoporosis, 95% confidence interval: 5.69, 1.32-24.53). Serum PTH, osteocalcin, 25-OH D, testosterone and creatinine levels increased after transplantation. Moreover, PTH correlated with creatinine and osteocalcin values. Bone mass decreased during the first 6 months and reached baseline values at the lumbar spine the second year, with posterior significant recovery at the femoral neck. Long term evolution of femoral neck BMD correlated with PTH levels. Six months after transplantation bone histomorphometric data showed an increase in bone formation parameters. After liver transplantation there is a high incidence of fractures, specially in elderly patients and those with osteoporosis. Bone mass decreased in the short-term period and improved, initially at the lumbar spine and later at the femur, according to histomorphometric evidences of an increase in bone formation. The increase in creatinine values induces a secondary hyperparathyroidism that influences the changes in femoral bone mass. Treatment of osteoporosis shortly after liver transplantation may be important in the prevention of bone fractures, particularly in patients with low bone mass.